Allison O’Connell

1.9k total citations · 2 hit papers
9 papers, 1.4k citations indexed

About

Allison O’Connell is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Allison O’Connell has authored 9 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Allison O’Connell's work include Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers) and CAR-T cell therapy research (2 papers). Allison O’Connell is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers) and CAR-T cell therapy research (2 papers). Allison O’Connell collaborates with scholars based in United States and Saudi Arabia. Allison O’Connell's co-authors include Cloud P. Paweletz, Geoffrey R. Oxnard, Pasi A. Jänne, Stacy L. Mach, Yanan Kuang, Paul T. Kirschmeier, Adrian G. Sacher, Ryan S. Alden, David M. Jackman and Nora Feeney and has published in prestigious journals such as Clinical Cancer Research, RNA and JAMA Oncology.

In The Last Decade

Allison O’Connell

9 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

2014 590 citations Geoffrey R. Oxnard, Cloud P. Paweletz et al. Clinical Cancer Research profile →
Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer

2016 432 citations Adrian G. Sacher, Cloud P. Paweletz et al. JAMA Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allison O’Connell United States	6	1.1k	933	659	448	218	9	1.4k
Stacy L. Mach United States	7	1.0k 1.0×	1.1k 1.2×	664 1.0×	456 1.0×	233 1.1×	13	1.5k
Sabrina Rajan United Kingdom	3	1.4k 1.3×	680 0.7×	727 1.1×	575 1.3×	412 1.9×	6	1.7k
Audrey Didelot France	17	762 0.7×	516 0.6×	626 0.9×	485 1.1×	319 1.5×	33	1.3k
Nicolas Pécuchet France	14	557 0.5×	600 0.6×	612 0.9×	366 0.8×	139 0.6×	31	1.1k
Francesco Pepe Italy	23	719 0.7×	890 1.0×	723 1.1×	531 1.2×	221 1.0×	108	1.5k
Nora Feeney United States	8	959 0.9×	1.1k 1.2×	772 1.2×	516 1.2×	245 1.1×	11	1.5k
Ryan S. Alden United States	10	1.0k 1.0×	1.2k 1.3×	719 1.1×	457 1.0×	264 1.2×	14	1.5k
Carmen Say United States	4	734 0.7×	406 0.4×	372 0.6×	471 1.1×	201 0.9×	9	1.0k
Patricia Vasalos United States	11	826 0.8×	562 0.6×	515 0.8×	359 0.8×	301 1.4×	27	1.2k
Neal Lindeman United States	7	644 0.6×	372 0.4×	339 0.5×	296 0.7×	216 1.0×	10	920

Countries citing papers authored by Allison O’Connell

Since Specialization

Citations

This map shows the geographic impact of Allison O’Connell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison O’Connell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison O’Connell more than expected).

Fields of papers citing papers by Allison O’Connell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison O’Connell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison O’Connell. The network helps show where Allison O’Connell may publish in the future.

Co-authorship network of co-authors of Allison O’Connell

This figure shows the co-authorship network connecting the top 25 collaborators of Allison O’Connell. A scholar is included among the top collaborators of Allison O’Connell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison O’Connell. Allison O’Connell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

O’Connell, Allison, et al.. (2019). Thermodynamic examination of pH and magnesium effect on U6 RNA internal loop. RNA. 25(12). 1779–1792. 4 indexed citations

O’Connell, Allison, Shangzi Wang, & Louis M. Weiner. (2019). Abstract A096: The potential role of fibroblast activation protein as a natural killer cell immune checkpoint. Cancer Immunology Research. 7(2_Supplement). A096–A096. 1 indexed citations

Aldeghaither, Dalal, David J. Zahavi, Joseph C. Murray, et al.. (2018). A Mechanism of Resistance to Antibody-Targeted Immune Attack. Cancer Immunology Research. 7(2). 230–243. 34 indexed citations

Kuang, Yanan, Allison O’Connell, Adrian G. Sacher, et al.. (2018). Monitoring of Response and Resistance in Plasma of EGFR-Mutant Lung Cancer Using Droplet Digital PCR. Methods in molecular biology. 1768. 193–207. 5 indexed citations

Zahavi, David J., Dalal Aldeghaither, Allison O’Connell, & Louis M. Weiner. (2018). Enhancing antibody-dependent cell-mediated cytotoxicity: a strategy for improving antibody-based immunotherapy. PubMed. 1(1). 7–12. 77 indexed citations

Yanagita, Masahiko, Amanda J. Redig, Cloud P. Paweletz, et al.. (2016). A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR -Mutant Non–Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial. Clinical Cancer Research. 22(24). 6010–6020. 92 indexed citations

Sacher, Adrian G., Cloud P. Paweletz, Suzanne E. Dahlberg, et al.. (2016). Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer. JAMA Oncology. 2(8). 1014–1014. 432 indexed citations breakdown →

Paweletz, Cloud P., Adrian G. Sacher, Ryan S. Alden, et al.. (2015). Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients. Clinical Cancer Research. 22(4). 915–922. 177 indexed citations

Oxnard, Geoffrey R., Cloud P. Paweletz, Yanan Kuang, et al.. (2014). Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA. Clinical Cancer Research. 20(6). 1698–1705. 590 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact